K Dinesh - M - 28 - 2024 - 2

K DINESH M, 28 years
Date of Test: 24 Feb 2024
Report for: K DINESH (28 yrs / M)

Tests Conducted: COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
Test Date: 24 Feb 2024

Report Status: Report Available
T echnically certified phlebotomists

R eport verified by expert pathologists
U nique bar code tracking for every sample
S ample tested by fully automated machines
T emperature controlled sample logistics
Registered Address : API Holdings Ltd., Lab Address: 13-9-1 BC ROAD NEW
902/A, Raheja GAJUWAKA VISAKHAPATNAM LOCALITY:
Plaza 1, Opp. R-City Mall, LBS Marg, GAJUWAKA LANDMARK: CITY: 7022 000 900
Ghatkopar
Sample (W),:13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM
Collected
VISAKHAPATNAM
LOCALITY: GAJUWAKA
Mumbai - CITY:
LANDMARK: 400086
VISAKHAPATNAM
Page 1 of 22
Report Availability Summary

94 Reports Available
Note: This is summary page. Please refer to the table below for the details
Test Report Status

COMPREHENSIVE FULL BODY CHECKUP WITH Available
VITAMIN D AND B12 - NEW
25-OH VITAMIN D (TOTAL) Available
COMPLETE URINE ANALYSIS Available
FASTING BLOOD SUGAR(GLUCOSE) Available
HEMOGRAM - 6 PART (DIFF) Available
HbA1c Available
IRON Available
KIDPRO Available
LIPID PROFILE Available
LIVER FUNCTION TESTS Available
TOTAL IRON BINDING CAPACITY (TIBC) Available
TOTAL THYROXINE (T4) Available
TOTAL TRIIODOTHYRONINE (T3) Available
TSH - ULTRASENSITIVE Available
UNSAT.IRON-BINDING CAPACITY(UIBC) Available
VITAMIN B-12 Available
Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

Page 2 of 22
LANDMARK: CITY: VISAKHAPATNAM
Your Health Summary

Thank you for trusting us with your health report.
Stay on top of your health parameters and take the right steps to stay healthy.
At a glance
Biologocal - Graphical representation of a blood vessel within a human body, for representation purpose only.
Thyroid Function Heart Function

Looks Good Needs Attention
All parameters are within range. HDL / LDL RATIO and 2 more
parameters are out of range.
Lungs Function Blood Count

Test Not Taken Needs Attention
LYMPHOCYTE and 3 more
parameters are out of range.
Liver Function Kidney Function

Looks Good Looks Good
All parameters are within range. All parameters are within range.
Anemia Studies Urinalysis

Looks Good
Needs Attention All parameters are within range.
IRON is out of range.
Vitamin Diabetes Monitoring Electrolytes and

Needs Attention Looks Good Minerals
VITAMIN B-12 and 1 more All parameters are within Test Not Taken
parameters are out of range. range.

Page 3 of 22
Out of Range Parameters

.
10/94 tests needs immediate attention
Test Name Parameters that need your attention

25-OH VITAMIN D (TOTAL) VITAMIN B-12
21.09 30-100 ng/mL 151 211-911 pg/mL
Vitamin
PLATELET DISTRIBUTION LYMPHOCYTE
WIDTH(PDW) 44.5 20-40 %
8.4 9.6-15.2 fL
Blood Count PLATELET TO LARGE CELL MEAN CORP.HEMO.CONC(MCHC)
RATIO(PLCR) 29.8 31.5-34.5 g/dL
13.9 19.7-42.4 %
IRON
62.8 65 - 175 µg/dL
Anemia Studies
HDL / LDL RATIO HDL CHOLESTEROL - DIRECT
0.31 > 0.40 Ratio 31 40-60 mg/dL
Heart Function LDL CHOLESTEROL - DIRECT

102 < 100 mg/dL

Page 4 of 22
Detailed Report
.
25-OH VITAMIN D (TOTAL)

Parameters Result Unit Reference Range
25-OH VITAMIN D (TOTAL) 21.09 ng/mL LOW
Technology: C.L.I.A 30 100
Reference Range: DEFICIENCY : <20 ng/ml
INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml
TOXICITY : >100 ng/ml
Method: Fully Automated Chemi Luminescent Immuno Assay

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome. Increase in vitamin D total levels indicate
Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.
Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.
VITAMIN B-12
VITAMIN B-12 151 pg/mL LOW
Technology: C.L.I.A 211 911
Reference Range: Normal : 211 - 911 pg/ml
Method: COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It is critical in normal
DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and
impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in conjunction with the patients medical
history, clinical examination and other findings.
Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml
Kit Validation reference:
Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby; 1987:569–73.
Sample Collected on (SCT): 24 Feb 2024 09:36 Sample Received on (SRT): 24 Feb 2024 02:29 Report Released on (RRT): 24 Feb 2024 04:16
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325
Note: Underlined values are critical Values, Clinician’s attention required. Dr Mary Lavanya MD(Path)

Page 5 of 22
Detailed Report
.
IRON
IRON 62.8 µg/dL LOW
Technology: PHOTOMETRY 65 175
Reference Range: Male : 65 - 175
Female : 50 - 170
Method: Ferrozine method without deproteinization
TOTAL IRON BINDING CAPACITY (TIBC)

TOTAL IRON BINDING CAPACITY (TIBC) 354.8 µg/dL NORMAL
Reference Range: Male : 225 - 535 µg/dl Female : 215 - 535 µg/dl
Method: Spectrophotometric Assay
% TRANSFERRIN SATURATION
% TRANSFERRIN SATURATION 17.7 % NORMAL
Technology: CALCULATED 13 45
Method: Derived from IRON and TIBC values
UNSAT.IRON-BINDING CAPACITY(UIBC)
UNSAT.IRON-BINDING CAPACITY(UIBC) 292 µg/dL NORMAL
Method: SPECTROPHOTOMETRIC ASSAY
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325

Page 6 of 22
Detailed Report
.
LIPID PROFILE
TOTAL CHOLESTEROL 155 mg/dL NORMAL
Technology: PHOTOMETRY ≤ 200
HDL CHOLESTEROL - DIRECT 31 mg/dL LOW

HDL / LDL RATIO 0.31 Ratio LOW

Technology: CALCULATED ≥ 0.4
LDL CHOLESTEROL - DIRECT 102 mg/dL HIGH

TC/ HDL CHOLESTEROL RATIO 4.9 Ratio NORMAL

TRIG / HDL RATIO 2.01 Ratio NORMAL

Technology: CALCULATED ≤ 3.12
TRIGLYCERIDES 63 mg/dL NORMAL

LDL / HDL RATIO 3.3 Ratio NORMAL

Technology: CALCULATED 1.5 3.5
NON-HDL CHOLESTEROL 123.83 mg/dL NORMAL

Technology: CALCULATED ≤ 160
VLDL CHOLESTEROL 12.6 mg/dL NORMAL

Method:
TRI/H - Derived from TRIG and HDL Values HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values LDL/ - Derived from serum HDL and LDL Values
TRIG - Enzymatic, End Point CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HD/LD - Derived from HDL and LDL values. TC/H - Derived from serum Cholesterol and Hdl values

Page 7 of 22
Detailed Report
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

CHOLESTEROL
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE 130-159 HIGH 200-499
HIGH
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325

Page 8 of 22
Detailed Report
.
LIVER FUNCTION TESTS

ALKALINE PHOSPHATASE 70 U/L NORMAL
BILIRUBIN - TOTAL 0.48 mg/dL NORMAL

Technology: PHOTOMETRY 0.3 1.2
BILIRUBIN -DIRECT 0.1 mg/dL NORMAL

Technology: PHOTOMETRY ≤ 0.3
BILIRUBIN (INDIRECT) 0.38 mg/dL NORMAL

Technology: CALCULATED ≤ 0.9
GAMMA GLUTAMYL TRANSFERASE 24.54 U/L NORMAL

(GGT) ≤ 55
Technology: PHOTOMETRY
SGOT / SGPT RATIO 1.09 Ratio NORMAL

Technology: CALCULATED ≤2
ASPARTATE AMINOTRANSFERASE 14.69 U/L NORMAL

(SGOT ) ≤ 35
Technology: PHOTOMETRY
ALANINE TRANSAMINASE (SGPT) 13.49 U/L NORMAL

PROTEIN - TOTAL 7.1 gm/dL NORMAL

ALBUMIN - SERUM 4.28 gm/dL NORMAL

SERUM GLOBULIN 2.82 gm/dL NORMAL

Technology: CALCULATED 2.5 3.4

Page 9 of 22
Detailed Report
LIVER FUNCTION TESTS
SERUM ALB/GLOBULIN RATIO 1.52 Ratio NORMAL
Technology: CALCULATED 0.9 2
Method:
BILT - Vanadate Oxidation BILD - Vanadate Oxidation
PROT - Biuret Method SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
GGT - Modified IFCC method A/GR - Derived from serum Albumin and Protein values
BILI - Derived from serum Total and Direct Bilirubin values SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
ALKP - Modified IFCC method OT/PT - Derived from SGOT and SGPT values.
SGPT - IFCC* Without Pyridoxal Phosphate Activation SGOT - IFCC* Without Pyridoxal Phosphate Activation
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325

Page 10 of 22
Detailed Report
.
TOTAL TRIIODOTHYRONINE (T3)

TOTAL TRIIODOTHYRONINE (T3) 101 ng/dL NORMAL
Technology: C.M.I.A 58 159
Method: Fully Automated Chemi Luminescent Microparticle Immunoassay

SUGGESTING THYRONORMALCY
TOTAL THYROXINE (T4)

TOTAL THYROXINE (T4) 8.21 µg/dL NORMAL
Technology: C.M.I.A 4.87 11.72

TSH - ULTRASENSITIVE
TSH - ULTRASENSITIVE 2.35 µIU/mL NORMAL
Technology: C.M.I.A 0.35 4.94

Disclaimer:
Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different
technologies and different reagents causing difference in reference ranges and hence it is recommended to interpret results with assay specific reference ranges
provided in the reports.
To diagnose and monitor therapy doses, it is recommended to get tested every time at the same laboratory.
Advice: For Abnormal thyroid profile report and patient not on medication / and or clinically indicated, Suggested further evaluation with FT3 and FT4 tests.
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325

Page 11 of 22
Detailed Report
.
KIDPRO
UREA (CALCULATED) 31.24 mg/dL Adult : 17-43
Technology: CALCULATED
BLOOD UREA NITROGEN (BUN) 14.6 mg/dL NORMAL

UREA / SR.CREATININE RATIO 39.05 Ratio NORMAL

Technology: CALCULATED ≤ 52
CREATININE - SERUM 0.8 mg/dL NORMAL

Reference Range: Male : 0.6 - 1.1
Female : 0.5 - 0.8
Clinical Significance:
The significance of a sin gle creatin in e value must be in terpreted in light of the patie nts muscle mass. A patie nt with a greater muscle mass wil have a higher creatin in e concentratio n.
The trend of serum creatin in e concentratio ns over time is more important than absolute creatin in e concentratio n. Serum creatin in e concentratio ns may in crease when an ACE in hibitor
(ACEI) is taken. The assay could be affected mildly and may result in anomalo us values if serum sample s have heterophilic antibodie s, hemolyzed , icteric or lipemic.
BUN / SR.CREATININE RATIO 18.25 Ratio 9:1-23:1

CALCIUM 9.6 mg/dL NORMAL

URIC ACID 7.06 mg/dL NORMAL

Method:
URIC - Uricase / Peroxidase Method UR/CR - Derived from UREA and Sr.Creatinine values.
B/CR - Derived from serum Bun and Creatinine values SCRE - Creatinine Enzymatic Method
BUN - Kinetic UV Assay. CALC - Arsenazo III Method, End Point.
UREAC - Derived from BUN Value.
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325

Page 12 of 22
Detailed Report
.
eGFR
EST. GLOMERULAR FILTRATION RATE 122 mL/min/1.73 m2 NORMAL
(eGFR) ≥ 90
Reference Range: > = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Method: CKD-EPI Creatinine Equation

Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate kidney injury is poorly inferred
from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard”
measurement for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It
cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret
information for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining. Application
of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med.
2009;150(9):604-12.
Sample Type : SERUM
Labcode : 2402082298/DG871
Barcode : CA782325

Page 13 of 22
Detailed Report
.
HbA1c
HbA1c 5.5 % NORMAL
Technology: H.P.L.C ≤ 5.7
Reference Range: Belo w 5.7% : Normal
5.7% - 6.4% : Prediabetic
>=6.5% : Diabetic
Guidance For Known Diabetics: Belo w 6.5% : Good Control
6.5% - 7% : Fair Control
7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method: Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG)

AVERAGE BLOOD GLUCOSE (ABG) 111 mg/dL NORMAL
Reference Range: 90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Note: Average Blo od Glucose value is calculated from HBA1c value and it in dicates Average Blo od Sugar le vel over past three months.
Method: Derived from HBA1c values
Sample Type : EDTA
Labcode : 2402082408/DG871
Barcode : BS697120

Page 14 of 22
Detailed Report
.
HEMOGRAM - 6 PART (DIFF)

TOTAL LEUCOCYTES COUNT (WBC) 6.41 X 10³ / µL NORMAL
Technology: HEMATOLOGY 4 10
NEUTROPHILS 47.1 % NORMAL

LYMPHOCYTE 44.5 % HIGH

MONOCYTES 5.5 % NORMAL

EOSINOPHILS 2.2 % NORMAL

BASOPHILS 0.5 % NORMAL

Technology: HEMATOLOGY ≤2
IMMATURE GRANULOCYTE 0.2 % NORMAL

PERCENTAGE(IG%) ≤ 0.5
Technology: HEMATOLOGY
NEUTROPHILS - ABSOLUTE COUNT 3.03 X 10³ / µL NORMAL

LYMPHOCYTES - ABSOLUTE COUNT 2.85 X 10³ / µL NORMAL

MONOCYTES - ABSOLUTE COUNT 0.35 X 10³ / µL NORMAL

Technology: HEMATOLOGY 0.2 1
BASOPHILS - ABSOLUTE COUNT 0.03 X 10³ / µL NORMAL

Technology: HEMATOLOGY 0.02 0.1

Page 15 of 22
Detailed Report
EOSINOPHILS - ABSOLUTE COUNT 0.14 X 10³ / µL NORMAL
IMMATURE GRANULOCYTES(IG) 0.01 X 10³ / µL NORMAL

Technology: HEMATOLOGY ≤ 0.3
TOTAL RBC 4.79 X 10^6/µL NORMAL

NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL NORMAL

Technology: HEMATOLOGY ≤ 0.5
NUCLEATED RED BLOOD CELLS % 0.01 % NORMAL

Technology: HEMATOLOGY ≤5
HEMOGLOBIN 13.1 g/dL NORMAL

HEMATOCRIT(PCV) 43.9 % NORMAL

MEAN CORPUSCULAR VOLUME(MCV) 91.6 fL NORMAL

MEAN CORPUSCULAR 27.3 pq NORMAL

HEMOGLOBIN(MCH) 27 32
MEAN CORP.HEMO.CONC(MCHC) 29.8 g/dL LOW

RED CELL DISTRIBUTION WIDTH - 42.7 fL NORMAL

SD(RDW-SD) 39 46

Page 16 of 22
Detailed Report
RED CELL DISTRIBUTION WIDTH (RDW- 12.8 % NORMAL
CV) 11.6 14
PLATELET DISTRIBUTION WIDTH(PDW) 8.4 fL LOW

MEAN PLATELET VOLUME(MPV) 8.6 fL NORMAL

Technology: HEMATOLOGY 6.5 12
PLATELET COUNT 345 X 10³ / µL NORMAL

PLATELET TO LARGE CELL RATIO(PLCR) 13.9 % LOW

PLATELETCRIT(PCT) 0.3 % NORMAL

Method: Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)

(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method (using a semiconductor laser), and
SLS- hemoglobin method)
*Please Correlate with clinical conditions.
Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.
Sample Type : EDTA
Labcode : 2402082408/DG871
Barcode : BS697120

Page 17 of 22
Detailed Report
.
FASTING BLOOD SUGAR(GLUCOSE)

FASTING BLOOD SUGAR(GLUCOSE) 97 mg/dL NORMAL
Method: GOD-PAP METHOD

Reference Range - As per ADA Guideline: Fasting Plasma Glucose (FPG)
Normal Prediabetes Diabetes

70 to 100 mg/dl 100 mg/dl to 125 mg/dl 126 mg/dl or higher
Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed , icteric or lipemic. The
concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and reagent specificity. For diagnostic purposes results
should always be assessed in conjunction with patients medical history, clinical findings and other findings.
Sample Type : FLUORIDE
Labcode : 2402082341/DG871
Barcode : BT306927

Page 18 of 22
Detailed Report
.
COMPLETE URINE ANALYSIS

Physical Examination
VOLUME 5 mL -
Technology: MICROSCOPY
COLOUR PALE YELLOW - Pale Yellow

APPEARANCE CLEAR - Clear

SPECIFIC GRAVITY 1.030 - NORMAL

Technology: MICROSCOPY 1.003 1.03
PH 6 - NORMAL
Technology: MICROSCOPY 5 8
Chemical Examination
URINARY PROTEIN ABSENT mg/dL Absent
URINARY GLUCOSE ABSENT mg/dL Absent

URINE KETONE ABSENT mg/dL Absent

URINARY BILIRUBIN ABSENT mg/dL Absent

UROBILINOGEN Normal mg/dL <=0.2

BILE SALT ABSENT - Absent


Page 19 of 22
Detailed Report
BILE PIGMENT ABSENT - Absent
URINE BLOOD ABSENT - Absent

NITRITE ABSENT - Absent

LEUCOCYTE ESTERASE ABSENT - Absent

Microscopic Examination
MUCUS ABSENT - Absent
RED BLOOD CELLS Absent cells/HPF NORMAL

Technology: MICROSCOPY ≤5
URINARY LEUCOCYTES (PUS CELLS) Absent cells/HPF NORMAL

EPITHELIAL CELLS Absent cells/HPF NORMAL

CASTS ABSENT - Absent

CRYSTALS ABSENT - Absent

BACTERIA ABSENT - Absent

YEAST ABSENT - Absent


Page 20 of 22
Detailed Report
PARASITE ABSENT - Absent
Method: Manual Dipstick Method, Microscopy
Sample Type : URINE
Labcode : 2402086569/DG871
Barcode : BS931282

Page 21 of 22
Terms & Conditions

Conditions of Reporting
The reported results are for information and interpretation of the referring doctor only. Only such medical professionals
who understand reporting units, reference ranges and limitations of technologies should interpret results.
It is presumed that the tests performed on the specimen belong to the patient, named or identified.
Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
Should the results indicate an unexpected abnormality, the same should be reconfirmed.
This report is not valid for medico-legal purpose.
Neither API Holdings Limited, nor its employees/representatives assume any liability, responsibility for any loss or
damage that may be incurred by any person as a result of presuming the meaning or contents of the report.
The tests are clinically tested by Thyrocare Technologies Limited.
For any support please contact at +91 7022000900 between 6am to 11pm.
Explanations
Majority of the specimen processed in the laboratory are collected by Pathologists / Hospitals / Franchise Partners we
call them as "Clients".
Patient Name: The name is as declared by the client and recored by the personnel who collected the specimen.
Referred by: The name of the doctor who has recommended testing as declared by the client (if applicable).
Labcode: This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
Barcode: This is the specimen identity number and it states that the results are for the specimen bearing the barcode
(irrespective of the name).
Collection: This is the location where the blood or specimen was collected as declared by the client.
Specimen Collection Time (SCT): The time when specimen was collected as declared by the client.
Specimen Receiving Time (SRT): This time when the specimen reached our laboratory.
Report Releasing Time (RRT): The time when our pathologist has released the values for reporting.
Reference Range: Means the range of values in which 95% of the normal population would fall.
T echnically certified phlebotomists

R eport verified by expert pathologists
U nique bar code tracking for every sample
S ample tested by fully automated machines
T emperature controlled sample logistics
Page 22 of 22

K Dinesh - M - 28 - 2024 - 2

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

K Dinesh - M - 28 - 2024 - 2

Uploaded by

Copyright:

Available Formats

K DINESH M, 28 years

Date of Test: 24 Feb 2024

Report for: K DINESH (28 yrs / M)

Test Date: 24 Feb 2024

T echnically certified phlebotomists

Report Availability Summary

Test Report Status

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

Your Health Summary

Thyroid Function Heart Function

Lungs Function Blood Count

Liver Function Kidney Function

Anemia Studies Urinalysis

Vitamin Diabetes Monitoring Electrolytes and

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

Out of Range Parameters

10/94 tests needs immediate attention

Test Name Parameters that need your attention

Heart Function LDL CHOLESTEROL - DIRECT

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

25-OH VITAMIN D (TOTAL)

Method: Fully Automated Chemi Luminescent Immuno Assay

Method: COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

Method: Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC)

Method: Spectrophotometric Assay

Method: Derived from IRON and TIBC values

Method: SPECTROPHOTOMETRIC ASSAY

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

HDL CHOLESTEROL - DIRECT 31 mg/dL LOW

HDL / LDL RATIO 0.31 Ratio LOW

LDL CHOLESTEROL - DIRECT 102 mg/dL HIGH

TC/ HDL CHOLESTEROL RATIO 4.9 Ratio NORMAL

TRIG / HDL RATIO 2.01 Ratio NORMAL

TRIGLYCERIDES 63 mg/dL NORMAL

LDL / HDL RATIO 3.3 Ratio NORMAL

NON-HDL CHOLESTEROL 123.83 mg/dL NORMAL

VLDL CHOLESTEROL 12.6 mg/dL NORMAL

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

TOTAL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

LIVER FUNCTION TESTS

BILIRUBIN - TOTAL 0.48 mg/dL NORMAL

BILIRUBIN -DIRECT 0.1 mg/dL NORMAL

BILIRUBIN (INDIRECT) 0.38 mg/dL NORMAL

GAMMA GLUTAMYL TRANSFERASE 24.54 U/L NORMAL

SGOT / SGPT RATIO 1.09 Ratio NORMAL

ASPARTATE AMINOTRANSFERASE 14.69 U/L NORMAL

ALANINE TRANSAMINASE (SGPT) 13.49 U/L NORMAL

PROTEIN - TOTAL 7.1 gm/dL NORMAL

ALBUMIN - SERUM 4.28 gm/dL NORMAL

SERUM GLOBULIN 2.82 gm/dL NORMAL

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

TOTAL TRIIODOTHYRONINE (T3)

Method: Fully Automated Chemi Luminescent Microparticle Immunoassay

TOTAL THYROXINE (T4)

Method: Fully Automated Chemi Luminescent Microparticle Immunoassay

Method: Fully Automated Chemi Luminescent Microparticle Immunoassay

Sample Collected :13-9-1 BC ROAD NEW GAJUWAKA VISAKHAPATNAM LOCALITY: GAJUWAKA

BLOOD UREA NITROGEN (BUN) 14.6 mg/dL NORMAL